Search Results
Search for other papers by Rong Wan in
Google Scholar
PubMed
Search for other papers by Chao Zhu in
Google Scholar
PubMed
Search for other papers by Rui Guo in
Google Scholar
PubMed
Search for other papers by Lai Jin in
Google Scholar
PubMed
Search for other papers by Yunxin Liu in
Google Scholar
PubMed
Search for other papers by Li Li in
Google Scholar
PubMed
Search for other papers by Hao Zhang in
Google Scholar
PubMed
Search for other papers by Shengnan Li in
Google Scholar
PubMed
biology, such as modulating local and systemic inflammation. Importantly, both AR and urocortin (UCN1) have been identified in vascular ECs ( Liu et al . 2003 , Kageyama et al . 2012 ). Endothelial UCN1 is upregulated by inflammatory cytokines ( Kohno
Search for other papers by Sian J S Simpson in
Google Scholar
PubMed
Search for other papers by Lorna I F Smith in
Google Scholar
PubMed
Search for other papers by Peter M Jones in
Google Scholar
PubMed
Search for other papers by James E Bowe in
Google Scholar
PubMed
Introduction The corticotropin-releasing hormone (CRH) peptide family comprises CRH and the structurally related urocortin peptides (UCN1, UCN2 and UCN3). These neuroendocrine peptides are best known for their involvement in regulating the
Departments of Obstetrics and Gynecology, Physiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan
Search for other papers by Kenichiro Watanabe in
Google Scholar
PubMed
Search for other papers by Takahiro Nemoto in
Google Scholar
PubMed
Search for other papers by Shigeo Akira in
Google Scholar
PubMed
Search for other papers by Toshiyuki Takeshita in
Google Scholar
PubMed
Search for other papers by Tamotsu Shibasaki in
Google Scholar
PubMed
& Vale 2006 ). Urocortin 2 (Ucn2) is a member of the CRF peptide family, which acts through binding to CRF type 2 receptor (CRF-R2). Others and we previously demonstrated that Ucn2 is expressed in both the brain and peripheral tissues, including the lung
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Pasquale Florio in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Giulia De Falco in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Eleonora Leucci in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Michela Torricelli in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Paulo B Torres in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Paolo Toti in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Arianna Dell’Anna in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Ennio Tiso in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Rosa Santopietro in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Lorenzo Leoncini in
Google Scholar
PubMed
Department of Human Pathology and Oncology, University of Siena, Policlinico ‘Le Scotte’ Viale Bracci, 53100 Siena, Italy
Search for other papers by Felice Petraglia in
Google Scholar
PubMed
and secretion of these factors may be involved in pathological conditions, such as endometrial adenocarcinoma. Among the locally produced brain peptides, urocortin (UCN) is one of the most recently identified. It is a 40-amino acid neuropeptide
Search for other papers by Takahiro Nemoto in
Google Scholar
PubMed
Search for other papers by Azusa Iwasaki-Sekino in
Google Scholar
PubMed
Search for other papers by Naoko Yamauchi in
Google Scholar
PubMed
Search for other papers by Tamotsu Shibasaki in
Google Scholar
PubMed
Introduction As a member of the corticotropin-releasing factor (CRF) family peptides, urocortin (Ucn 1) was discovered by screening of a rat brain cDNA library with a probe derived from carp urotensin I ( Vaughan et al. 1995
Search for other papers by Yuqing Wu in
Google Scholar
PubMed
Search for other papers by Yinyan Xu in
Google Scholar
PubMed
Search for other papers by Hong Zhou in
Google Scholar
PubMed
Search for other papers by Jin Tao in
Google Scholar
PubMed
Search for other papers by Shengnan Li in
Google Scholar
PubMed
exerts profound immunosuppressive effects ( Chrousos 1995 ). More recently, a new member of the CRH family, urocortin (UCN), was cloned and shown to be expressed in the central nervous system of rats ( Vaughan et al. 1995 ) and man ( Donaldson et
Search for other papers by Takahiro Nemoto in
Google Scholar
PubMed
Search for other papers by Naoko Yamauchi in
Google Scholar
PubMed
Search for other papers by Tamotsu Shibasaki in
Google Scholar
PubMed
actions of CRF are induced through two subtypes of CRF receptor (CRF-R), the CRF-R1 and the CRF-R2, with a higher affinity to CRF-R1 than to CRF-R2 ( Chen et al . 1993 , Perrin et al . 1993 , Lovenberg et al . 1995 a ). Urocortins 2 (Ucn 2), one of
Search for other papers by Manon M Roustit in
Google Scholar
PubMed
Search for other papers by Joan M Vaughan in
Google Scholar
PubMed
Search for other papers by Pauline M Jamieson in
Google Scholar
PubMed
Search for other papers by Mark E Cleasby in
Google Scholar
PubMed
treatments available. However, recent work has demonstrated that generalised overexpression of urocortin 3 (UCN3) in mice results in both hypertrophy and increased glucose disposal into muscle ( Jamieson et al . 2011 ), making this an interesting candidate
Search for other papers by Jessica L Huang in
Google Scholar
PubMed
Search for other papers by Sharon Lee in
Google Scholar
PubMed
Search for other papers by Pelle Hoek in
Google Scholar
PubMed
Search for other papers by Talitha van der Meulen in
Google Scholar
PubMed
Search for other papers by Richard Van in
Google Scholar
PubMed
Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, California, USA
Search for other papers by Mark O Huising in
Google Scholar
PubMed
, most beta cells do not express MAFA at this early age and remain largely functionally immature. Additional markers, such as the peptide hormone Urocortin 3 (UCN3), have emerged as late beta cell maturity markers in recent years. UCN3 is a member of
Search for other papers by Mark E Cleasby in
Google Scholar
PubMed
Search for other papers by Pauline M Jamieson in
Google Scholar
PubMed
Search for other papers by Philip J Atherton in
Google Scholar
PubMed
protein metabolism. Published effects of insulin, insulin-like growth factor 1 (IGF1), amino acids, myostatin, urocortins and vitamin D on signalling pathways and effector machinery (glucose transporters, mitochondrial function, translation and activation